The DOI matches its Crossref record, with a small difference in title or year; 49 of the 49 references it cites were found in a registry or an index.
Th1 (IL-2, interferon-gamma (IFN-γ)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
Open accessAbstract
SUMMARY: We investigated the production of IL-2, IFN-γ, IL-10 and IL-4 by PBMC from 24 patients with SLE and 10 healthy individuals. Basal and mitogen-stimulated (lipopolysaccharide and phytohaemagglutinin (LPS + PHA)) cytokine production was determined in a whole blood assay (WBA). Supernatants were collected and assayed with specific ELISAs. Although the IL-2 and IFN-γ contents did not differ significantly between patients and controls under both conditions, statistically significant correlations were found between each cytokine and disease activity (SLAM index) after stimulation (respectively, r= 0.501, P = 0.01 and r = 0.631, P = 0.001). PBMC IL-10 production was significantly higher for patients than controls (P = 0.05), but no correlation between IL-10 levels and the SLAM index was obtained. IL-4 production was not statistically different between SLE patients and controls. For stimulated WBAs, the IL-10/IL-2 and IL-10/IFN-γ ratios were significantly correlated with disease severity (P = 0.02; P = 0.001, respectively). Overall, our data suggest that SLE is characterized by an elevated production of IL-10, reflecting the basal state of activation of the immune system. During exacerbation of SLE, IL-2 and IFN-γ are synthesized in larger amounts and may cause the tissue damage observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In adaptative immune regulation, •NO inhibits the lymphocytes T helper 1 (Th1 is a population characterized by the release of IL-2 and IFN-γ) and promotes Th2 lymphocytes, which leads to humoral immunity and allergic responses [113].”
From The Role of Reactive Species on Innate Immunity (2022) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Moore, K. W., O’Garra, A., Malefyt, R. D. W., Vieira, P., & Mosmann, T. R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001121 · Cited by 1,883
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,866
Lymphokine Production by Human T Cells in Disease States
Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001303 · Cited by 1,332
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
Cherwinski, H., Schumacher, J., Brown, K., & Mosmann, T. (1987) · Journal of Experimental Medicine · doi:10.1084/jem.166.5.1229 · Cited by 1,118
Human TH1 and TH2 subsets: doubt no more
Romagnani, S. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90120-i · Cited by 1,079
Research works printed but not linked: 5
- 10.1146/annurev.immunol.7.1.145 · DOI · Paper page
- Asherson RA, 1988, J Rheumatol, 15, 1742
- Llorente L, 1993, Eur Cytokine Netw, 4, 421
- 10.1146/annurev.immunol.11.1.165 · DOI
- Draeger AM, 1986, Clin Exp Immunol, 64, 80
Cited by
Sorted by citations
Wong, C. K., Lit, L. C. W., Tam, L., Li, E. K. M., Wong, P. T. Y., & Lam, C. W. K. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.019 · Cited by 535
Talaat, R. M., Mohamed, S. F., Bassyouni, I. H., & Raouf, A. A. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.027 · Cited by 494
Oxidative stress and human health
Rahman, T., Hosen, M. I., Islam, M. M., & Shekhar, H. U. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.327123 · Cited by 514
“Elevated levels of F2-isoprostane are associated with oxidant injury to tissue in a variety of disorders including ischemiareperfusion injury, atherosclerosis, diabetes and autoimmune disease [205,206].”
BackgroundWong, C. K., Ho, C. Y., Li, E. K., & Lam, C. (2000) · Lupus · doi:10.1191/096120300678828703 · Cited by 471
Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus
Chun, H.-Y., Chung, J.-W., Kim, H., Yun, J., Jeon, J., Ye, Y., Kim, S., Park, H., & Suh, C. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9104-0 · Cited by 390
“Concentrations of IFN-γ are increased in SLE patients, and the production of IFN-γ by PBMCs from SLE patients is significantly correlated with global disease activity [13, 29].”
BackgroundCytokine profile in Behçet's disease patients
Hamzaoui, K., Hamzaoui, A., Guémira, F., Bessioud, M., Hamza, M., & Ayed, K. (2002) · Scandinavian Journal of Rheumatology · doi:10.1080/030097402320318387 · Cited by 312
“Similar results were observed in mixed connective tissue disease (24) and in systemic lupus erythematosus (25).”
ResultThe Th1 life cycle: molecular control of IFN-γ to IL-10 switching
Cope, A. P., Friec, G. L., Cardone, J., & Kemper, C. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.03.010 · Cited by 254
Cytokines and systemic lupus erythematosus
Dean, G. S., Tyrrell-Price, J., Crawley, E. M., & Isenberg, D. A. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.4.243 · Cited by 230
Beebe, A. M., Cua, D. J., & Malefyt, R. D. W. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00025-4 · Cited by 215
Roles of Pro- and Anti-Inflammatory Cytokines in the Pathogenesis of SLE
Su, D., Lu, Z., Shen, M., Li, X., & Sun, L. (2012) · BioMed Research International · doi:10.1155/2012/347141 · Cited by 202
“[139] J.”
BackgroundLit, L. C. W., Wong, C. K., Tam, L., Li, E. K. M., & Lam, C. W. K. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038315 · Cited by 181
Mishra, N., Brown, D. R., Olorenshaw, I. M., & Kammer, G. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051507098 · Cited by 179
Current prospects of type II interferon γ signaling and autoimmunity
Green, D. S., Young, H. A., & Valencia, J. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.774745 · Cited by 181
Pattarini, L., Trichot, C., Bogiatzi, S. I., Grandclaudon, M., Meller, S., Keuylian, Z., Durand, M., Volpe, E., Madonna, S., Cavani, A., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20150402 · Cited by 173
Mondal, S., Varma, S., Bamola, V. D., Naik, S. N., Mirdha, B. R., Padhi, M. M., Mehta, N., & Mahapatra, S. C. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.05.012 · Cited by 164
Fraser, D. A., Laust, A. K., Nelson, E. L., & Tenner, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902232 · Cited by 172
“Additionally, HMDMs and iDCs expression patterns for IL-10 and MCP-1/CCL2, two other cytokines that have been associated with Th2 polarization (30, 31), were not concordant with that in the monocyte.”
ResultGomez, D. I., Corréa, P., Gómez, L. M., Cadena, J., Molina, J. F., & Anaya, J. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2003.11.002 · Cited by 161
Wong, C. K., Lit, L. C. W., Tam, L., Li, E. K., & Lam, C. W. K. (2005) · Rheumatology · doi:10.1093/rheumatology/keh663 · Cited by 159
Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus
Dolff, S., Bijl, M., Huitema, M. G., Limburg, P. C., Kallenberg, C. G. M., & Abdulahad, W. H. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.08.005 · Cited by 156
Chang, J.-W., Hung, S.-P., Wu, H.-H., Wu, W.-M., Yang, A., Tsai, H.-L., Yang, L.-Y., & Lee, O. K. (2010) · Cell Transplantation · doi:10.3727/096368910x520056 · Cited by 154
Csiszár, A., Nagy, G. Y., Gergely, P., Pozsonyi, T., & Pócsik, É. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01369.x · Cited by 147
Hervier, B., Béziat, V., Haroche, J., Mathian, A., Lebon, P., Ghillani‐Dalbin, P., Musset, L., Debré, P., Amoura, Z., & Vieillard, V. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30313 · Cited by 144
“Notably, IFN has been shown to be involved in SLE pathogenesis (40,41).”
BackgroundThe Role of Reactive Species on Innate Immunity
Andrés, C., Pérez de la Lastra, J., Juan, C., Plou, F., & Pérez-Lebeña, E. (2022) · Vaccines · doi:10.3390/vaccines10101735 · Cited by 142
“In adaptative immune regulation, •NO inhibits the lymphocytes T helper 1 (Th1 is a population characterized by the release of IL-2 and IFN-γ) and promotes Th2 lymphocytes, which leads to humoral immunity and allergic responses [113].”
BackgroundBiomarkers in systemic lupus erythematosus: II. Markers of disease activity
Illei, G. G., Tackey, E., Lapteva, L., & Lipsky, P. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20345 · Cited by 142
Lawrence, D. A., & McCabe, M. J. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00180-1 · Cited by 139
Increased serum interleukin 17 in patients with systemic lupus erythematosus
Zhao, X., Pan, H., Yuan, H., Zhang, W., Li, X.-P., Wang, G., Wu, G., Su, H., Pan, F., Li, W.-X., et al. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9533-3 · Cited by 137
Wong, C. K., Wong, P. T. Y., Tam, L., Li, E. K., Chen, D. P., & Lam, C. W. K. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9325-5 · Cited by 137
Dong, L., Ito, S., Ishii, K. J., & Klinman, D. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20810 · Cited by 134
Rönnelid, J., Tejde, A., Mathsson, L., Nilsson-Ekdahl, K., & Nilsson, B. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.1.37 · Cited by 130
Foxp3, Regulatory T Cell, and Autoimmune Diseases
Tao, J.-H., Cheng, M., Tang, J.-P., Liu, Q., Pan, F., & Li, X.-P. (2016) · Inflammation · doi:10.1007/s10753-016-0470-8 · Cited by 129
Enhanced Tryptophan Degradation in Systemic Lupus Erythematosus
Widner, B., Sepp, N. T., Kowald, E., Ortner, U., Wirleitner, B., Fritsch, P. O., Baier-Bitterlich, G., & Fuchs, D. (2000) · Immunobiology · doi:10.1016/s0171-2985(00)80079-0 · Cited by 128
Wong, C. K., Li, E. K., Ho, C. Y., & Lam, C. W. K. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.10.1078 · Cited by 122
Wang, Y., Ito, S., Chino, Y., Goto, D., Matsumoto, I., 村田, 秀., Tsutsumi, A., Hayashi, T., Uchida, K., Usui, J., et al. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04031.x · Cited by 122
Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis
Calvani, N., Richards, H., Tucci, M., Pannarale, G., & Silvestris, F. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02588.x · Cited by 120
Wong, C., Lit, L. C., Tam, L.-S., Li, E., & Lam, C.-W.-K. (2005) · Rheumatology · doi:10.1093/rheumatology/keh558 · Cited by 115
Wong, C. K., Ho, A. M. ‐., Tong, P. C. Y., Yeung, C. Y., Kong, A. P. S., Lun, S. W., Chan, J. C. N., & Lam, C. W. K. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03389.x · Cited by 115
Zizzo, G., & Cohen, P. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0081-4 · Cited by 94
Oxidative stress in systemic lupus erythematosus: Relationship to Th1 cytokine and disease activity
Shah, D., Kiran, R., Wanchu, A., & Bhatnagar, A. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.01.005 · Cited by 100
IFN-γ, should not be ignored in SLE
Liu, W., Zhang, S., & Wang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954706 · Cited by 105
Glucocorticoid Regulates Interleukin-37 in Systemic Lupus Erythematosus
Song, L., Qiu, F., Fan, Y., Ding, F., Liu, H., Shu, Q., Liu, W., & Li, X. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9791-z · Cited by 95
“Studies showed that IFN-γ was increased at both the RNA and protein levels in SLE patients, particularly those in the active stages of the disease [6, 7, 31, 32], and the overexpression of IFN-γ contributed to the immunopathogenesis of SLE.”
Estrogen Receptor Signaling and Its Relationship to Cytokines in Systemic Lupus Erythematosus
Kassi, E. N., & Moutsatsou, P. (2010) · BioMed Research International · doi:10.1155/2010/317452 · Cited by 95
Macrophage subpopulations in systemic lupus erythematosus.
Orme, J. J., & Mohan, C. (2012) · PubMed · Cited by 93
McCarthy, E. M., Smith, S. M., Lee, R. Z., Cunnane, G., Doran, M. F., Donnelly, S. C., Howard, D., O’Connell, P. R., Kearns, G. M., Gabhann, J. N., et al. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/ket428 · Cited by 88
Yu, H., Yang, Y., Jiang, T., Zhang, X., Zhao, Y., Pang, G., Feng, Y., Zhang, S., Wang, F., Wang, Y., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b07804 · Cited by 87
Liu, Z., Yuan, X., Luo, Y., He, Y., Jiang, Y., Chen, Z. K., & Sun, E. (2009) · Cytokine · doi:10.1016/j.cyto.2008.12.003 · Cited by 85
Wong, C. K., Ho, C. Y., Li, E. K., Tam, L., & Lam, C. W. K. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01989.x · Cited by 85
Lin, S.-Y., Hsieh, S.-C., Lin, Y.-C., Lee, C.-N., Tsai, M.-H., Lai, L.-C., Chuang, E. Y.-Y., Chen, P.-C., Hung, C.-C., Chen, L.-Y., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.74 · Cited by 83
Yu, S., Kuan, W.-P., Wong, C. K., Li, E. K., & Tam, L. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/715190 · Cited by 83
“The ratios of Th1 and Th2 cytokines have been investigated to determine the cytokine homeostasis in order to determine whether Th1 or Th2 predominance during the development of SLE [2, 3].”
BackgroundActivation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice
Dong, J., Wang, Q.-X., Zhou, C.-Y., Ma, X.-F., & Zhang, Y.-C. (2007) · Lupus · doi:10.1177/0961203306075383 · Cited by 77
Godot, V., Harraga, S., Beurton, I., Tiberghien, P., Sarciron, M. E., Gottstein, B., & Vuitton, D. A. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01309.x · Cited by 77
Hudson, C. A., Cao, L., Kasten‐Jolly, J., Kirkwood, J., & Lawrence, D. A. (2003) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390306456 · Cited by 75
“It has also been found that, at the time of initiation, there is a transient increase in the IL-10/IL-12 ratio that is followed by an increase in the Th1 cytokines (Horwitz et al., 1997; Viallard et al., 1999).”
BackgroundTolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus
Esmaeili, S., Mahmoudi, M., Momtazi‐Borojeni, A. A., Sahebkar, A., Doulabi, H., & Rastin, M. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25748 · Cited by 77
“During exacerbation of SLE, IFN-γ is synthesized in larger amounts which may contribute in the tissue damage observed (Viallard et al., 1999).”
BackgroundInhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus
Wang, J., Mizui, M., Zeng, L., Bronson, R. T., Finnell, M. D., Terhorst, C., Kyttaris, V. C., Tsokos, G. C., Zhang, Z., & Kontaridis, M. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87037 · Cited by 74
Mathematical model of sarcoidosis
Hao, W., Crouser, E. D., & Friedman, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417789111 · Cited by 73
Biomarkers in systemic lupus erythematosus
Illei, G. G., & Lipsky, P. E. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0013-4 · Cited by 73
Systemic lupus erythematosus: pathogenesis and targeted therapy
Su, X., Yu, H. M., Lei, Q., Chen, X., Tong, Y., Zhang, Z., Yang, W., Guo, Y., & Lin, L. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00217-8 · Cited by 84
“Research has demonstrated that SLE patients exhibit elevated serum levels of IFN-γ compared to healthy controls [233–236].”
Genetic Susceptibility to Atopic Dermatitis
Kiyohara, C., Tanaka, K., & Miyake, Y. (2008) · Allergology International · doi:10.2332/allergolint.r-07-150 · Cited by 68
Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis
Chan, R. W. Y., Tam, L., Li, E. K., Lai, F. M., Chow, K., Lai, K., Li, P. K., & Szeto, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11062 · Cited by 68
Barcellini, W., Clerici, G., Montesano, R., Taioli, E., Morelati, F., Rebulla, P., & Zanella, A. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02380.x · Cited by 67
Dolff, S., Quandt, D., Wilde, B., Feldkamp, T., Hua, F., Cai, X., Specker, C., Kribben, A., Kallenberg, C. G. M., & Witzke, O. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3100 · Cited by 65
“Th1 cells secrete interferon gamma (INF-g) and are induced by IL-12, whereas Th2 cells secrete IL-4, IL-5 and IL-13 and are induced by IL-4 [1,2].”
BackgroundMączyńska, I., Millo, B., Ratajczak-Stefańska, V., Maleszka, R., Szych, Z., Kurpisz, M. K., & Giedrys‐Kalemba, S. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.08.001 · Cited by 66
Decreased serum IL-22 levels in patients with systemic lupus erythematosus
Pan, H., Zhao, X., Yuan, H., Zhang, W., Li, X.-P., Wang, G., Wu, G., Tang, X., Li, W.-X., Li, L., et al. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.11.009 · Cited by 64
“Until recently, Th1 dominant immune responses have been generally considered to be pathological in autoimmune disease via the induction of inflammatory reaction, and large amounts of Th1 cytokines such as interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and IL-12 have been found in SLE [3,4].”
BackgroundWu, X., Li, Y., Chen, X., Zhou, Z., Pang, J., Luo, X., & Kong, M. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00448c · Cited by 62
T cell receptor repertoire of T cells in the kidneys of patients with lupus nephritis
村田, 秀., Matsumura, R., Kôyama, A., Sugiyama, T., Sueishi, M., Shibuya, K., Tsutsumi, A., & Sumida, T. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10432 · Cited by 57
Kuo, M.-C., Chang, C.-Y., Cheng, T.-L., & Wu, M. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-0880-5 · Cited by 56
“In peripheral blood, not only is the natural cell–cell interactions preserved but also circulating stimulatory and inhibitory mediators are present at their physiological concentrations (Viallard et al. 1999).”
BackgroundAlizadeh, A. M., Isanejad, A., Sadighi, S., Mardani, M., Kalaghchi, B., & Hassan, Z. M. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02996-y · Cited by 56
Wong, C. K., Tse, P. S., Wong, E. L., Leung, P. C., Fung, K., & Lam, C. W. K. (2003) · International Immunopharmacology · doi:10.1016/j.intimp.2003.12.003 · Cited by 55
Patients with Systemic Lupus Erythematosus
Byun (1999) · American family physician · Cited by 53
Immunoregulation of NKT Cells in Systemic Lupus Erythematosus
Chen, J., Wu, M. C., Wang, J., & Li, X. (2015) · Journal of Immunology Research · doi:10.1155/2015/206731 · Cited by 52
“The imbalance between Th1 and Th2 cytokines participates in the immunoregulation of SLE [29, 40].”
BackgroundSlavíková, M., Schmeisser, H., Kontseková, E., Mateička, F., Borecky, L., & KONTSEK, P. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003321532475 · Cited by 51
la Cruz-Mosso, U. D., García‐Iglesias, T., Bucala, R., Estrada‐García, I., González-López, L., Cerpa‐Cruz, S., Parra‐Rojas, I., Gámez-Nava, J. I., Pérez-Guerrero, E. E., & Muñóz-Valle, J. F. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.010 · Cited by 51
Chan, R. W. Y., Lai, F. M., Li, E. K., Tam, L., Chow, K., Li, P. K., & Szeto, C. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk102 · Cited by 47
Cathepsin S inhibition suppresses autoimmune-triggered inflammatory responses in macrophages
Thanei, S., Theron, M., Silva, A. P., Reis, B., Branco, L., Schirmbeck, L. A., Kolb, F. A., Haap, W. J., Schindler, T. H., & Trendelenburg, M. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.10.001 · Cited by 46
Avian pathogenic Escherichia coli (APEC) infection alters bone marrow transcriptome in chickens
Sun, H., Liu, P., Nolan, L. K., & Lamont, S. J. (2015) · BMC Genomics · doi:10.1186/s12864-015-1850-4 · Cited by 45
Yu, H., Liu, P., Lin, Y., Chen, W. J., Lee, J., Wang, L., Yang, Y., & Chiang, B. (2010) · Lupus · doi:10.1177/0961203310371152 · Cited by 44
Hale, M. B., Krutzik, P. O., Samra, S. S., Crane, J., & Nolan, G. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006756 · Cited by 45
Zhang, Y., Li, Z., Wu, H., Wang, J., & Zhang, S. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115004 · Cited by 43
The Function of CD3+CD56+NKT-Like Cells in HIV-Infected Individuals
Jiang, Y., Cui, X., Chen, C., Zhang, J., Zhou, F., Zhang, Z., Fu, Y., Xu, J., Chu, Z., Liu, J., et al. (2014) · BioMed Research International · doi:10.1155/2014/863625 · Cited by 43
Salazar‐Camarena, D. C., Ortiz‐Lazareno, P. C., Marín‐Rosales, M., Cruz, Á., Muñoz‐Valle, F., Tapia‐Llanos, R., Orozco‐Barocio, G., Machado-Contreras, J. R., & Palafox‐Sánchez, C. A. (2018) · Cytokine · doi:10.1016/j.cyto.2018.11.008 · Cited by 42
Macrophages and neutrophils in SLE—An online molecular catalog
Orme, J. J., & Mohan, C. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.10.010 · Cited by 42
“Contrary to its classical designation as an anti-inflammatory cytokine, IL-10 contributes directly to SLE pathogenesis.”
BackgroundInfluentialTyrrell-Price, J., Lydyard, P. M., & Isenberg, D. A. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01466.x · Cited by 42
Bao, Y. X., Wong, C. K., Leung, S. F., Chan, A. T. �., Li, P. W., Wong, E. L., Leung, P., Fung, K., Yin, Y. B., & Lam, C. W. K. (2006) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2006.12.771 · Cited by 41
Interferon-γ polymorphisms in systemic lupus erythematosus
Lee, J., GOLDMAN, D. W., Piliero, L. M., Petri, M., & Sullivan, K. E. (2001) · Genes and Immunity · doi:10.1038/sj.gene.6363775 · Cited by 41
Activation of Peripheral Th17 Lymphocytes in Patients with Asthma
Wong, C. K., Lun, S. W., Ko, F. W. S., Wong, P. T. Y., Hu, S. Q., Chan, I. H.-S., Hui, D. S. C., & Lam, C. W. K. (2009) · Immunological Investigations · doi:10.1080/08820130903062756 · Cited by 40
Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects
Arora, V., Verma, J., Marwah, V., Kumar, A., Anand, D., & Das, N. (2012) · Lupus · doi:10.1177/0961203311434937 · Cited by 40
Yang, X., Sun, B., Wang, H., Cheng, Y., Xiaole, W., & Ji, X. (2015) · Journal of Biomedical Research · doi:10.7555/jbr.29.20130037 · Cited by 39
Shaim, H., Estrov, Z. E., Harris, D., Sanabria, M. H., Liu, Z., Ruvolo, P. P., Thompson, P. A., Ferrajoli, A., Daher, M., Burger, J. A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01773 · Cited by 38
Shen, M., Chen, X., Huang, L., Yu, Q., Chen, Y., & Xie, J. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104321 · Cited by 39
Fagiolo, E. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00085-5 · Cited by 38
Wong, C. K., Ho, A. M. ‐., Tong, P. C. Y., Yeung, C. Y., Chan, J. C. N., Kong, A. P. S., & Lam, C. W. K. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9137-4 · Cited by 38
Szodoray, P., Gál, I., Baráth, S., Aleksza, M., Horváth, I. F., Gergely, P., Szegedi, G., Nakken, B., & Zeher, M. (2008) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740801910361 · Cited by 38
“IL-10 and IFN-c levels depend strongly on the level of immune activation in patients with autoimmune diseases (38).”
BackgroundInterleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy
Zhou, Y., Yoshida, S., Kubo, Y., Kobayashi, Y., Nakama, T., Yamaguchi, M., Ishikawa, K., Nakao, S., Ikeda, Y., Ishibashi, T., et al. (2016) · Scientific Reports · doi:10.1038/srep28140 · Cited by 38
Elewa, E. A., Zakaria, O., Mohamed, E. I., & Boghdadi, G. (2013) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2013.10.003 · Cited by 37
Inhibition of Lupus by Genetic Alteration of the Interferon-α/β Receptor
Kono, D. H., Baccalà, R., & Theofilopoulos, A. N. (2003) · Autoimmunity · doi:10.1080/08916930310001624665 · Cited by 37
IL-10 and the Cytokine Network in the Pathogenesis of Human Autoimmune Hemolytic Anemia
Toriani-Terenzi, C., & Fagiolo, E. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1361.044 · Cited by 37
Nair, N., Vinod, V., Suresh, M. K., Vijayrajratnam, S., Biswas, L., Peethambaran, R., Vasudevan, A. K., & Biswas, R. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.03.047 · Cited by 36
Changes in Serum Cytokines May Predict Therapeutic Efficacy of Tofacitinib in Rheumatoid Arthritis
Li, Y., Yuan, L., Yang, J. W., Lei, Y., Zhang, H., Xia, L., Shen, H., & Lu, J. (2019) · Mediators of Inflammation · doi:10.1155/2019/5617431 · Cited by 37
“CD4+Th lymphocytes can be divided into Th1 (IFN-γ, IL-2, and TNF-β) and Th2 (IL-4, IL-6, IL-10, and IL-13) subsets on the basis of their cytokines secretion profile [15].”
BackgroundLupus patients with pulmonary involvement have a pro-inflammatory cytokines profile
Al-Mutairi, S., Al-Awadhi, A. M., Raghupathy, R., Al-Khawari, H., Sada, P. N., Al-Herz, A. A., & Rawoot, P. (2006) · Rheumatology International · doi:10.1007/s00296-006-0268-3 · Cited by 36
Scavuzzi, B. M., Simão, A. N. C., Iriyoda, T. M. V., Lozovoy, M. A. B., Stadtlober, N. P., Santos, L. F. D. R. F., Flauzino, T., de Medeiros, F. A., de Sá, M. C., Consentin, L., et al. (2017) · Immunologic Research · doi:10.1007/s12026-017-8960-9 · Cited by 35
Dolff, S., Quandt, D., Feldkamp, T., Jun, C., Mitchell, A., Hua, F., Specker, C., Kribben, A., Witzke, O., & Wilde, B. (2014) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2013.869830 · Cited by 35
Metadata
- Authors
- VIALLARD, J. F., PELLEGRIN, J. L., RANCHIN, V, SCHAEVERBEKE, T., DEHAIS, J., LONGY-BOURSIER, M., RAGNAUD, J. M., LENG, B., & MOREAU, J. F.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- Laboratoire Immunotech, Marseille
- Hôpital Pellegrin (FR)
- Service de Médecine Interne, Hôpital Saint-André
- Corresponding author
- VIALLARD, J F
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-01
- Volume
- 115
- Issue
- 1
- Pages
- 189-195
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- PMC
- PMC1905189
- OpenAlex
- W2030175762
- Cited by
- 247
- References
- 48
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 8 · 2023: 13 · 2022: 10 · 2021: 7 · 2020: 9 · 2019: 9 · 2018: 5 · 2017: 7 · 2016: 12 · 2015: 11 · 2014: 16 · 2013: 4 · 2012: 13
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical & Experimental Immunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- systemic lupus erythematosus, Th1/Th2 balance, interleukin-2, interferon-gamma, IL-10, IL-4, peripheral blood mononuclear cells, disease activity, cytokine ratios, immune activation, tissue damage
- MeSH terms
- Adolescent, Adult, Female, Humans, Interferon-gamma, Interleukin-2, Leukocytes, Mononuclear, Lupus Erythematosus, Systemic, Male, Middle Aged, Interleukin-4, Cytokines, Interleukin-10, Th1 Cells, Th2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review